Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human ACADL Antikörper:
anti-Rat (Rattus) ACADL Antikörper:
anti-Mouse (Murine) ACADL Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal ACADL Primary Antibody für ELISA, WB - ABIN559742
Tucci, Herebian, Sturm, Seibt, Spiekerkoetter: Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid ?-oxidation. in PLoS ONE 2012
Human Polyclonal ACADL Primary Antibody für IHC (p), WB - ABIN652476
Geillinger, Rathmann, Köhrle, Fiamoncini, Daniel, Kipp: Hepatic metabolite profiles in mice with a suboptimal selenium status. in The Journal of nutritional biochemistry 2014
Cow (Bovine) Polyclonal ACADL Primary Antibody für WB - ABIN2778159
Lea, Abbas, Sprecher, Vockley, Schulz: Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. in Biochimica et biophysica acta 2000
Show all 2 Pubmed References
the fatty acid oxidation pathway and LCAD are factors contributing to the pathophysiology of pulmonary disease
Sirtuin 3 (SIRT3 (zeige SIRT3 Antikörper)) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site.
LCAD is minimally expressed in human skeletal muscle and likely does not play a significant role in long-chain fatty acid oxidation.
SIRT3 (zeige SIRT3 Antikörper) may play an essential role in attenuating lipid accumulation in the heart through the deacetylation of LCAD
Carnitine supplementation lowered myocardial triglycerides, normalizing myocardial triglycerides levels in LCAD Knock-out mice.
LCAD KO mice are ineffective in maintaining metabolic homeostasis during fasting, which is reflected by an impaired myocardial energy status in fasted LCAD KO mice.
mice with an inherited deficiency of very long-chain acyl-CoA dehydrogenase (VLCAD (zeige ACADVL Antikörper)), were protected from high-fat diet-induced obesity and liver and muscle insulin (zeige INS Antikörper) resistance.
LCAD is deacetylated in wild-type mice under fasted conditions and by SIRT3 (zeige SIRT3 Antikörper) in vitro and in vivo; hyperacetylation of LCAD reduces its enzymatic activity
These data demonstrate that primary defects in mitochondrial fatty acid oxidation capacity can lead to diacylglycerol accumulation, PKCepsilon (zeige PRKCE Antikörper) activation, and hepatic insulin (zeige INS Antikörper) resistance.
Novel candidate genes in T1D CD55 (zeige CD55 Antikörper) and Acadl were identified.
substantial cardiac hypertrophy in LCAD-deficient mice
The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in fatty acid and branched chain amino-acid metabolism. This protein is one of the four enzymes that catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid. Defects in this gene are the cause of long-chain acyl-CoA dehydrogenase (LCAD) deficiency, leading to nonketotic hypoglycemia.
, long-chain specific acyl-CoA dehydrogenase, mitochondrial
, acyl-Coenzyme A dehydrogenase, long chain
, long-chain acyl-CoA dehydrogenase
, Acyl Coenzyme A dehydrogenase, long chain
, LCAD long chain acyl-CoA dehydrogenase
, acetyl-Coenzyme A dehydrogenase, long-chain
, acyl-Coenzyme A dehydrogenase, long-chain